ESSA PHARMA INC (EPIX) Stock Price, Quote, News and Overview
NASDAQ:EPIX - Nasdaq - CA29668H7085 - Common Stock - Currency: USD
EPIX Quote, Performance and Key Statistics
1.72
-0.03 (-1.71%)
The current stock price of EPIX is 1.72 USD. In the past month the price decreased by -1.15%. In the past year, price decreased by -78.17%.
EPIX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About EPIX
Company Profile
ESSA Pharma, Inc. is a clinical stage pharmaceutical company. The company is headquartered in Vancouver, British Columbia and currently employs 50 full-time employees. The company went IPO on 2021-02-22. The firm is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, Masofaniten (formerly EPI-7386), is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). Masofaniten is in development in combination with antiandrogen treatments in patients with prostate cancer who are earlier in their course of the disease. The firm is completing the clinical development of masofaniten as a monotherapy treatment for patients with metastatic castration-resistant prostate cancer (mCRPC).
Company Info
ESSA PHARMA INC
999 West Broadway, Suite 720
Vancouver BRITISH COLUMBIA V5Z 1K5 CA
CEO: David Parkinson
Employees: 50
Company Website: https://www.essapharma.com/
Investor Relations: https://investors.essapharma.com/
Phone: 17783310962
ESSA PHARMA INC / EPIX FAQ
What is the stock price of ESSA PHARMA INC today?
The current stock price of EPIX is 1.72 USD. The price decreased by -1.71% in the last trading session.
What is the ticker symbol for ESSA PHARMA INC stock?
The exchange symbol of ESSA PHARMA INC is EPIX and it is listed on the Nasdaq exchange.
On which exchange is EPIX stock listed?
EPIX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ESSA PHARMA INC stock?
9 analysts have analysed EPIX and the average price target is 1.89 USD. This implies a price increase of 9.71% is expected in the next year compared to the current price of 1.72. Check the ESSA PHARMA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ESSA PHARMA INC worth?
ESSA PHARMA INC (EPIX) has a market capitalization of 76.35M USD. This makes EPIX a Micro Cap stock.
How many employees does ESSA PHARMA INC have?
ESSA PHARMA INC (EPIX) currently has 50 employees.
What are the support and resistance levels for ESSA PHARMA INC (EPIX) stock?
ESSA PHARMA INC (EPIX) has a support level at 1.72 and a resistance level at 1.87. Check the full technical report for a detailed analysis of EPIX support and resistance levels.
Should I buy ESSA PHARMA INC (EPIX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of EPIX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of EPIX, evaluating the profitability, health, valuation and growth aspects
- ESSA PHARMA INC (EPIX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ESSA PHARMA INC (EPIX) Sales and EPS estimates to see what analysts future expectations are.
- ESSA PHARMA INC (EPIX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ESSA PHARMA INC (EPIX) Insider and Institutional Ownership to learn about the owners and their transactions.
- ESSA PHARMA INC (EPIX) Stock Chart to make your own analysis
- ESSA PHARMA INC (EPIX) Latest news and press-releases to stay up to date.
Does ESSA PHARMA INC (EPIX) stock pay dividends?
EPIX does not pay a dividend.
When does ESSA PHARMA INC (EPIX) report earnings?
ESSA PHARMA INC (EPIX) will report earnings on 2025-05-12, before the market open.
What is the Price/Earnings (PE) ratio of ESSA PHARMA INC (EPIX)?
ESSA PHARMA INC (EPIX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.69).
What is the Short Interest ratio of ESSA PHARMA INC (EPIX) stock?
The outstanding short interest for ESSA PHARMA INC (EPIX) is 1.47% of its float. Check the ownership tab for more information on the EPIX short interest.
EPIX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to EPIX. When comparing the yearly performance of all stocks, EPIX is a bad performer in the overall market: 94.22% of all stocks are doing better.
EPIX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to EPIX. No worries on liquidiy or solvency for EPIX as it has an excellent financial health rating, but there are worries on the profitability.
EPIX Financial Highlights
Over the last trailing twelve months EPIX reported a non-GAAP Earnings per Share(EPS) of -0.69. The EPS decreased by -16.95% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -25.37% | ||
| ROE | -26.19% | ||
| Debt/Equity | 0 |
EPIX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 49% to EPIX. The Buy consensus is the average rating of analysts ratings from 9 analysts.